Advance Embryology Solutions Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: NI682988

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		482		-

			482		-
CURRENT ASSETS
Debtors	5	33,756		-
Cash at bank and in hand		5,840		739

		39,596		739
Creditors: Amounts Falling Due Within One Year	6	(41,699 )		(966 )

NET CURRENT ASSETS (LIABILITIES)			(2,103 )		(227 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(1,621 )		(227 )

NET LIABILITIES			(1,621 )		(227 )

CAPITAL AND RESERVES
Called up share capital	7		2		2
Profit and Loss Account			(1,623 )		(229 )

SHAREHOLDERS' FUNDS			(1,621)		(227)

Page 1

Page 2

Advance Embryology Solutions Ltd

Balance Sheet (continued)

As At 31 October 2025

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Dr Robbie Kerr

Director

29th July 2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

Advance Embryology Solutions Ltd is a private company, limited by shares, incorporated in Northern Ireland, registered number NI682988 . The registered office is 48 Bachelors Walk, Lisburn, BT28 1XN.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings	33.33% Straight Line
Computer Equipment	33.33% Straight Line

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2024: NIL)

4. Tangible Assets

	Fixtures & Fittings	Computer Equipment	Total
	£	£	£
Cost
As at 1 November 2024	417	-	417
Additions	-	660	660

As at 31 October 2025	417	660	1,077

Depreciation
As at 1 November 2024	278	139	417
Provided during the period	139	39	178

As at 31 October 2025	417	178	595

Net Book Value
As at 31 October 2025	-	482	482

As at 1 November 2024	139	(139 )	-

5. Debtors

	2025	2024
	£	£
Due within one year
Other debtors	33,756	-

Page 3

Page 4

Advance Embryology Solutions Ltd

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

6. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	1	-
Other creditors	41,698	966

	41,699	966

7. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	2	2